QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 262 filers reported holding QIAGEN NV in Q1 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,123 | -68.2% | 247 | -65.4% | 0.00% | – |
| Q2 2021 | $35,000 | -34.0% | 714 | -34.3% | 0.00% | -100.0% |
| Q1 2021 | $53,000 | -7.0% | 1,086 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $57,000 | +1.8% | 1,087 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $56,000 | +27.3% | 1,081 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | +2.3% | 1,022 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $43,000 | -32.8% | 1,022 | -46.1% | 0.00% | 0.0% |
| Q4 2019 | $64,000 | +23.1% | 1,897 | +21.0% | 0.00% | 0.0% |
| Q3 2019 | $52,000 | +8.3% | 1,568 | +33.3% | 0.00% | 0.0% |
| Q2 2019 | $48,000 | 0.0% | 1,176 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $48,000 | +17.1% | 1,176 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $41,000 | -8.9% | 1,176 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $45,000 | +4.7% | 1,176 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $43,000 | -30.6% | 1,176 | -38.9% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | +3.3% | 1,924 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $60,000 | -1.6% | 1,924 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $61,000 | – | 1,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |